NCT07766174

Brief Summary

The overall objective of this pilot study is to assess the feasibility of a RCT comparing Lōvu-augmented with usual prenatal care at UU. This would be a critical next step toward our long-term goal to identify technology-based interventions to improve maternal mental health in the Intermountain West. Our central hypothesis is that Lōvu will be both feasible and have high patient and clinician satisfaction, and that Lōvu-generated data will be a promising substrate for AI-based mental health risk stratification.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
69mo left

Started Sep 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 14, 2026

Completed
18 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2031

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2032

Last Updated

August 14, 2026

Status Verified

August 1, 2026

Enrollment Period

4.7 years

First QC Date

June 2, 2026

Last Update Submit

August 10, 2026

Conditions

Keywords

PregnantMental Health Check-Ins and SupportAppCare NavigatorReal-Time Vital Signs DataNutrition and Wellness GuidanceEducation and Birthing SupportExercise and Pelvic Floor Rehab

Outcome Measures

Primary Outcomes (1)

  • Feasibility Outcomes

    Recruitment rate and retention rate at 12 months

    12 Months

Secondary Outcomes (4)

  • Mental Health Screening Completion & Clinical Care Metrics

    12 Months

  • Care Utilization

    12 Months

  • Satisfaction & Usability

    12 Months

  • AI Preparation

    12 Months

Study Arms (2)

Lōvu-Augmented Arm

EXPERIMENTAL

The intervention is pragmatic in that the only thing patients are actually asked to do is enroll in Lovu, which is facilitated by the research and clinical personnel after randomization. After enrollment, they are not specifically instructed to do anything accept engage with Lovu as prompted (e.g. in response to reminders to measure BP and submit perinatal depression screening questionnaires) and to use Lovu as a resource for questions and concerns. The data generated by the participant's engagements with Lovu (vital sign measurements, questions, concerns, screening results) will be summarized and transmitted to the clinical team on a weekly basis ), which the team can make use of in clinical care. An example of a clinical impact would be that home BP monitoring with automated transmission of data to the clinical team can improve early detection of preeclampsia and other pregnancy complications.

Behavioral: Lōvu platform

Standard Care Arm

ACTIVE COMPARATOR

Mental health screening via PHQ-9, GAD-7, EPDS, and NIDA Quick Screen (these are all validated surveys) at least three times during your pregnancy: early in pregnancy, at least once later in pregnancy, and then at least once in the postpartum period.

Behavioral: Standard Care Arm

Interventions

Lōvu platformBEHAVIORAL

Standard prenatal care + Lōvu platform. Participant receives a Bluetooth-enabled scale, BP cuff, and handheld fetal Doppler. Orientation to Lōvu app and device use. Lōvu-generated data (e.g., weight, BP, HR) will be visible to the Lovu team and sent to the UU clinical team weekly Participant-reported outcomes (satisfaction, usability) collected via System Usability Scale (SUS)

Lōvu-Augmented Arm

Standard prenatal care per UU clinical protocols Mental health screening via PHQ-9, GAD-7, EPDS, and NIDA Quick Screen at standard intervals (these are all validated surveys) Data collected from EHR.

Standard Care Arm

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant people receiving care at University of Utah Clinics
  • Less than 14 weeks gestation at enrollment

You may not qualify if:

  • Patients enrolled in other studies utilizing remote monitoring

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Utah Hospital

Salt Lake City, Utah, 84132, United States

RECRUITING

MeSH Terms

Conditions

Alzheimer DiseaseMotor Activity

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersBehavior

Study Officials

  • Nathan Blue, MD, MPh

    University of Utah, Department of OBGYN

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be recruited and randomized into two different groups running in parallel to each other
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Associate Professor

Study Record Dates

First Submitted

June 2, 2026

First Posted

August 14, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

April 30, 2031

Study Completion (Estimated)

April 30, 2032

Last Updated

August 14, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations